Immunosuppressive drug FTY720 sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.

被引：0

作者：

Pshezhetskiy, Dmitry ^{[1
,2
]}

Bohler, Torsten ^{[3
]}

Doumerc, Nicolas ^{[4
]}

Golzio, Muriel ^{[2
]}

Brinkmann, Volker ^{[5
]}

Waxman, Jonathan ^{[1
]}

Malavaud, Bernard ^{[4
]}

Cuvillier, Olivier ^{[2
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, London, England

[2] IPBS, Toulouse, France

[3] Fac Med Toulouse, INSERM, U466, F-31073 Toulouse, France

[4] Hop Rangueil, Toulouse, France

[5] Novartis Pharmaceut, Basel, Switzerland

来源：

FASEB JOURNAL | 2008年 / 22卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：1

共 50 条

[1] IMMUNOSUPPRESSIVE DRUG FTY720 SENSITIZES PROSTATE CANCER CELLS TO RADIOTHERAPY BY INHIBITION OF SPHINGOSINE KINASE-1
Pshezhetskiy, Dmitry
Boehler, Torsten
Doumerc, Nicolas
Golzio, Muriel
Tessie, Justin
Brinkmann, Volker
Malavaud, Bernard
Waxman, Jonathan
Cuvillier, Olivier
ANTICANCER RESEARCH, 2008, 28 (5C) : 3453 - 3453
[2] FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
Pchejetski, Dmitri
Bohler, Torsten
Brizuela, Leyre
Sauer, Lysann
Doumerc, Nicolas
Golzio, Muriel
Salunkhe, Vishal
Teissie, Justin
Malavaud, Bernard
Waxman, Jonathan
Cuvillier, Olivier
CANCER RESEARCH, 2010, 70 (21) : 8651 - 8661
[3] Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720
Allende, ML
Sasaki, T
Kawai, H
Olivera, A
Mi, YD
van Echten-Deckert, G
Hajdu, R
Rosenbach, M
Keohane, CA
Mandala, S
Spiegel, S
Proia, RL
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) : 52487 - 52492
[4] FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells
Tonelli, Francesca
Lim, Keng Gat
Loveridge, Carolyn
Long, Jaclyn
Pitson, Stuart M.
Tigyi, Gabor
Bittman, Robert
Pyne, Susan
Pyne, Nigel J.
CELLULAR SIGNALLING, 2010, 22 (10) : 1536 - 1542
[5] Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
Zemann, B
Kinzel, B
Müller, M
Reuschel, R
Mechtcheriakova, D
Urtz, N
Bornancin, F
Baumruker, T
Billich, A
BLOOD, 2006, 107 (04) : 1454 - 1458
[6] Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate
Chiba, K
Hoshino, Y
Ohtsuki, M
Kataoka, H
Maeda, Y
Matsuyuki, H
Sugahara, K
Kiuchi, M
Hirose, R
Adachi, K
TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 102 - 106
[7] A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine
Tanaka, T
Takahara, S
Hatori, M
Suzuki, K
Wang, JD
Ichimaru, N
Suzuki, S
Morozumi, K
Okuyama, A
Yamanaka, H
CANCER LETTERS, 2002, 181 (02) : 165 - 171
[8] Inhibition of sphingosine 1-phosphate signaling by FTY720 ameliorates murine nonalcoholic steatohepatitis
Mauer, Amy S.
Malhi, Harmeet
HEPATOLOGY, 2016, 64 : 749A - 750A
[9] FTY720 Analogues as Sphingosine Kinase 1 Inhibitors ENZYME INHIBITION KINETICS, ALLOSTERISM, PROTEASOMAL DEGRADATION, AND ACTIN REARRANGEMENT IN MCF-7 BREAST CANCER CELLS
Lim, Keng G.
Tonelli, Francesca
Li, Zaiguo
Lu, Xuequan
Bittman, Robert
Pyne, Susan
Pyne, Nigel J.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 18633 - 18640
[10] Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice
Kataoka, H
Ohtsuki, M
Shimano, K
Mochizuki, S
Oshita, K
Murata, M
Sugahara, K
Sato, N
Hoshino, Y
Chiba, K
TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 107 - 109

← 1 2 3 4 5 →